CONTACT US
This podcast discusses the commercial real estate shortage for the nation’s biotech sector, and life science and biotech hubs like Boston and San Fran.

Biotech Faces a Real Estate Shortage

   

In this episode of TechTalk, we learn about the real estate shortage in the nation’s biotech hubs, the challenges of obtaining and creating new space, how early-stage companies are coping, and what’s on the drawing board to help alleviate the shortage.


Transcript

Dave Plaskow: Hello, and welcome to EisnerAmper’s technology podcast series. With more than 500 hundred technology clients, we’re always interested in the latest industry trends and developments, as well as any related business and accounting opportunities and challenges. This time, we’re turning our attention to the biotech sector, specifically, the challenge of biotechs finding available real estate. I’m your host, Dave Plaskow, and with us today is Dave Katz, Senior Manager in EisnerAmper’s Technology and Life Sciences Practice. We like to call this the Dave & Dave show. Dave, welcome, and thanks for being here.

Dave Katz: Thanks Dave.


More Podcasts in This Series
Lessons Learned from the Theranos Dissolution

EisnerAmper’s Technology and Life Sciences practice talks about the Theranos dissolution, and what took them from biotech unicorn to dissolution. Investors must use due diligence and consider a company's internal controls before investing in companies with high valuations.


Ride Sharing Capped in NYC

EisnerAmper's Technology podcast series discusses the proposed New York City Council cap on the number of ridesharing vehicles such as Lyft and Uber in Manhattan to ease congestion. How will this cap change Uber's valuation, and what is the economic hit to the taxi industry?


New Cryptocurrency Focuses on Price Stability

This episode of the Dave & Dave Show discusses new cryptocurrency technology from the fintech startup company Circle, called USD Coin. This cryptocurrency ties itself to the U.S. Dollar, therefore eliminates some volatility that comes with crypto mining and Bitcoin.



John Pennett has public accounting experience with a strong emphasis on life sciences companies. Member New Jersey Society of Certified Public Accountants and New Jersey Technology Council and advisory board of eLabs.

Contact John

* Required